A-317491 sodium salt hydrate

• Catalog No.: A2979
• M. F.: C33H29NNaO9
• M. W.: 606.57443
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: 5-{[(3-phenoxyphenyl)methyl][(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl}benzene-1,2,4-tricarboxylic acid hydrate sodium
• IUPAC Traditional name: 5-{[(3-phenoxyphenyl)methyl][(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]carbamoyl}benzene-1,2,4-tricarboxylic acid hydrate sodium
• Synonyms: 5-[[[(3-Phenoxyphenyl)methyl][(1S)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]carbonyl]-1,2,4-benzenetricarboxylic acid sodium salt hydrate

PROPERTIES

• Empirical Formula (Hill Notation): C33H27NO8 · xNa+ · yH2O
• Purity: ≥98% (HPLC)
• Apperance: white powder
• Solubility: H2O: >50 mg/mL
• Personal Protective Equipment: Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
• German water hazard class: 3

DETAILS

Description (简体中文)

Biochem/physiol Actions
Novel P2X3 and P2X2/3 receptor antagonist
Legal Information
Subject to U.S. Patent No. 6,831,193. Sold under license from Abbott Laboratories

Description (English)

Biochem/physiol Actions
Novel P2X3 and P2X2/3 receptor antagonist
Legal Information
Subject to U.S. Patent No. 6,831,193. Sold under license from Abbott Laboratories